FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Fresenius Hit With 11-Item FDA-483

FDA releases an 11-item Form FDA-483 from a 10/2023 Fresenius Kabi Oncology inspection at the companys Pradesh, India manufacturing facility.

latest-news-card-1
Human Drugs

e-Submission Guide for BIMO Inspection Planning

FDA posts a final guidance entitled Standardized Format for Electronic Submission of NDA and BLA Content for the Planning of Bioresearch Monitoring (B...

latest-news-card-1
Federal Register

Panel to Discuss Opioid Abuse Studies

Federal Register notice: FDA announces a 2/5 joint meeting of its Drug Safety and Risk Management Advisory Committee and Anesthetic and Analgesic Drug...

latest-news-card-1
Federal Register

Drug/Biologic Accelerated Approval Draft Guide

Federal Register notice: FDA makes available a draft guidance entitled Expedited Program for Serious Conditions Accelerated Approval of Drugs and Bio...

latest-news-card-1
Medical Devices

GE Healthcare Recalls Newborn Incubators

GE Healthcare has recalled its Giraffe Omnibed Carestation and Incubator Carestation due to the potential for excessive formaldehyde exposure.

latest-news-card-1
Human Drugs

Groups Urge Rare Disease Voucher Reauthorization

A letter from dozens of patient advocacy groups urges congressional leaders to pass the Creating Hope Reauthorization Act, which would reauthorize the...

Biologics

FDA Loses Again in FOIA Suit on Vaccine Records

A Texas federal court rules against FDA in an ongoing Freedom of Information Act lawsuit and it must now produce EUA supporting documents in addition ...

latest-news-card-1
Medical Devices

FDA Finds Lab Issues at Musk Plant

Reuters says FDA has informed Congress about a 2023 agency inspection at Elon Musks Neuralink that found animal lab issues that warranted voluntary co...

latest-news-card-1
Human Drugs

Updated Accelerated Approval Guidance

FDA publishes a draft guidance updating its accelerated approval policies and procedures based on new authority from the 2023 Consolidated Appropriati...

latest-news-card-1
Biologics

Genentech sBLA for Columvi Accepted for Review

FDA accepts for review a Genentech supplemental BLA for Columvi (glofitamab-gxbm) in combination with gemcitabine and oxaliplatin for treating patien...